You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

childhood grade III meningioma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Childhood Choroid Plexus Tumor, Childhood Ependymoblastoma, Childhood Grade III Meningioma Trial in United States (palbociclib

Terminated
Has Results
  • Childhood Choroid Plexus Tumor
  • +18 more
  • palbociclib isethionate
  • +2 more
  • Los Angeles, California
  • +10 more
Feb 10, 2021

Meningioma Trial in Chicago, Boston (AZD2014)

Active, not recruiting
  • Meningioma
  • Chicago, Illinois
  • +2 more
Oct 15, 2022

Residual, Progressive or Recurrent Grade II or III Meningioma Trial (NEO100)

Not yet recruiting
  • Residual, Progressive or Recurrent Grade II or III Meningioma
  • (no location specified)
Aug 25, 2021

Brain and CNS Tumors Trial in Geneva (adjuvant therapy, radiation therapy)

Active, not recruiting
  • Brain and Central Nervous System Tumors
  • adjuvant therapy
  • radiation therapy
  • Geneva, Switzerland
    Hopital Cantonal Universitaire de Geneve
Feb 2, 2021

Brain and CNS Tumors Trial in Canada, United States (54 Gy radiotherapy, 60 Gy radiotherapy)

Active, not recruiting
Has Results
  • Brain and Central Nervous System Tumors
  • 54 Gy radiotherapy
  • 60 Gy radiotherapy
  • Phoenix, Arizona
  • +77 more
Dec 15, 2022

Meningioma Trial (Radiotherapy 68 Gy(RBE), Radiotherapy 72 Gy(RBE), Radiotherapy 60 Gy(RBE))

Not yet recruiting
  • Meningioma
  • Radiotherapy 68 Gy(RBE)
  • +2 more
  • (no location specified)
Aug 2, 2022

Grade II Meningioma, Intracranial Meningioma Trial in Worldwide (Clinical Observation, Radiation Therapy)

Recruiting
  • Grade II Meningioma
  • Intracranial Meningioma
  • Clinical Observation
  • Radiation Therapy
  • Birmingham, Alabama
  • +184 more
Jan 13, 2022

Role of the Tumor Microenvironment in Aggressive Meningiomas

Not yet recruiting
  • Meningioma
  • Surgical waste and Data collect
  • (no location specified)
Apr 7, 2023

68-Ga DOTATATE PET/MRI in Diagnosis and Management of

Recruiting
  • CNS Tumors
  • +6 more
  • Ga68-DOTATATE-PET/MRI
  • New York, New York
    Weill Cornell Medicine
Sep 20, 2022

Oncological Care for Patients With Meningioma

Recruiting
  • Atypical Meningioma
  • +5 more
    • Montpellier, France
      Uh Montpellier
    Apr 13, 2022

    Hematopoietic/Lymphoid Cancer, Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission

    Completed
    • Hematopoietic/Lymphoid Cancer
    • +135 more
    • beclomethasone dipropionate
    • +4 more
    • Hackensack, New Jersey
    • +1 more
    Feb 1, 2021

    Meningioma Trial in Vandœuvre-lès-Nancy (Everolimus)

    Not yet recruiting
    • Meningioma
    • Vandœuvre-lès-Nancy, Grand Est, France
    • +1 more
    Nov 8, 2023

    Meningiomas Trial in Boston (Nivolumab - 240 mg, Ipilimumab - 1 mg/kg, Nivolumab - 480 mg)

    Recruiting
    • Meningiomas
    • Nivolumab - 240 mg
    • +4 more
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Jan 3, 2022

    Grade 1 Meningioma, Grade 2 Meningioma, Grade 3 Meningioma Trial in Rochester (radiation, drug, procedure, other)

    Recruiting
    • Grade 1 Meningioma
    • +4 more
    • Gallium Ga 68-DOTATATE
    • +5 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jan 11, 2023

    Meningioma, Malignant Trial in Beijing (Sintilimab)

    Recruiting
    • Meningioma, Malignant
    • Beijing, Beijing, China
      Beijing TianTan Hospital
    Aug 9, 2021

    Meningioma, Meningioma Atypical, Anaplastic Meningioma Trial in Rome (Biological biomarker assessment)

    Recruiting
    • Meningioma
    • +2 more
    • Biological biomarker assessment
    • Rome, Italy
      Fondazione Policlinico Universitario A. Gemelli IRCCS
    Mar 29, 2023

    Meningioma Trial in Austria, Germany, United States (Gleolan (Aminolevulinic Acid Hydrochloride/ALA/ALA-HCI))

    Active, not recruiting
    • Meningioma
    • Gleolan (Aminolevulinic Acid Hydrochloride/ALA/ALA-HCI)
    • Phoenix, Arizona
    • +16 more
    Dec 27, 2022

    Oral Mucositis, Childhood Acute Lymphoblastic Leukemia Trial (Laser Therapy, Sham procedure)

    Not yet recruiting
    • Oral Mucositis
    • Childhood Acute Lymphoblastic Leukemia
    • Laser Therapy
    • Sham procedure
    • (no location specified)
    Jul 7, 2022

    Brain Stem Glioma, Cerebral Astrocytoma, Childhood Cerebellar Anaplastic Astrocytoma Trial in Canada, United States

    Active, not recruiting
    Has Results
    • Brain Stem Glioma
    • +4 more
    • Bevacizumab
    • +2 more
    • Birmingham, Alabama
    • +136 more
    Oct 15, 2022

    Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With

    Active, not recruiting
    • Adult Acute Lymphoblastic Leukemia in Remission
    • +46 more
    • Philadelphia, Pennsylvania
      Thomas Jefferson University
    Feb 10, 2021

    Intracranial Meningioma, Recurrent Meningioma, NF2 Gene Mutation Trial in United States (Vismodegib, FAK Inhibitor GSK2256098,

    Recruiting
    • Intracranial Meningioma
    • +2 more
    • Birmingham, Alabama
    • +707 more
    Sep 25, 2022

    Drug Induced Neuropathy in Children With ALL

    Recruiting
    • Acute Lymphocytic Leukemia
      • Trieste, Friuli Venezia Giulia, Italy
        IRCCS materno infantile Burlo Garofolo
      Mar 31, 2023

      Cavernous Sinus Meningioma, Proton-therapy, Photon Radiotherapy Trial in France (Proton-therapy, Photon radiotherapy)

      Not yet recruiting
      • Cavernous Sinus Meningioma
      • +3 more
      • Proton-therapy
      • Photon radiotherapy
      • Caen, France
      • +6 more
      May 31, 2023

      High Grade Glioma, Meningioma, Embryonal Tumor Trial in United States (LUTATHERA® (Lutetium Lu 177 dotatate))

      Recruiting
      • High Grade Glioma
      • +12 more
      • LUTATHERA® (Lutetium Lu 177 dotatate)
      • Aurora, Colorado
      • +8 more
      Jan 16, 2023

      Precision Medicine for Every Child With Cancer

      Recruiting
      • Childhood Cancer
      • +5 more
      • Whole Genome Sequencing
      • +6 more
      • Adelaide, Australia
      • +8 more
      Jan 24, 2023